GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 783 filers reported holding GLAXOSMITHKLINE PLC in Q2 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $301,000 | -29.5% | 7,200 | -27.3% | 0.06% | -11.3% |
Q2 2017 | $427,000 | -29.0% | 9,900 | -36.5% | 0.06% | -32.6% |
Q4 2016 | $601,000 | +56.5% | 15,600 | +75.3% | 0.09% | -13.2% |
Q3 2016 | $384,000 | +47.7% | 8,900 | +39.1% | 0.11% | -5.4% |
Q1 2016 | $260,000 | +11.1% | 6,400 | +10.3% | 0.11% | +36.6% |
Q4 2015 | $234,000 | -17.3% | 5,800 | +9.4% | 0.08% | -1.2% |
Q1 2014 | $283,000 | – | 5,300 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |